Young Adults Who Ever Received HPV Vaccine on the Rise

From 2013 to 2018, there was an increase in the percentage of adults aged 18 to 26 years who received one or more doses or the recommended number of doses of human papillomavirus (HPV) vaccine, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

Peter Boersma, M.P.H., and Lindsey I. Black, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, describe trends in self-reported HPV vaccination initiation and completion by selected demographic characteristics among adults aged 18 to 26 years.

The researchers found that from 2013 to 2018, there was an increase in the percentage of adults aged 18 to 26 years who ever received one or more doses of HPV vaccine, from 22.1 to 39.9 percent. Similarly, there was an increase in the percentage of adults who received the recommended number of doses of HPV vaccine, from 13.8 to 21.5 percent. Compared with Hispanic adults, non-Hispanic white adults were more likely to have ever received one or more doses of HPV vaccine in 2018. The majority of adults aged 18 to 26 years who ever received one or more doses of HPV vaccine received the first dose between ages 13 and 17 years.

"Monitoring vaccination prevalence may help inform strategies to increase HPV vaccination rates," the authors write.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.